Effect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients
Condition(s):Traumatic Brain InjuryLast Updated:June 7, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Traumatic Brain InjuryLast Updated:June 7, 2016Completed
Condition(s):Breast Neoplasms; Dermatitis; Prevention & Control; Epigallocatechin GallateLast Updated:April 5, 2019Unknown status
Condition(s):Lung Neoplasms; Esophagitis; Prevention & Control; Epigallocatechin GallateLast Updated:April 28, 2020Unknown status
Condition(s):Papilloma; Cervix LesionLast Updated:December 22, 2022Completed
Condition(s):COVID-19; SARS-CoV2Last Updated:September 9, 2020Unknown status
Condition(s):Papilloma-induced Cervical LesionsLast Updated:January 25, 2024Active, not recruiting
Condition(s):Diet, Food Choice, TasteLast Updated:May 25, 2023Terminated
Condition(s):Cognitive Function; MoodLast Updated:April 13, 2012Completed
Condition(s):ObesityLast Updated:February 9, 2009Completed
Condition(s):Esophageal ObstructionLast Updated:September 10, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.